PharmaMar coronavirus

PharmaMar - Sousa

“Plitidepsin, The Most Powerful Antiviral, Has Been Shown To Be Effective Against The Coronavirus”

Pedro A. Muñoz | PharmaMar has just announced positive results for its APLICOV trial with Aplidin against COVID-19. This antiviral achieves the primary safety objective and the secondary efficacy goal, as well as a significant reduction in viral load and C-reactive protein (CRP) in hospitalized patients. A few days before this news, the company’s president, José María Fernández Sousa-Faro, gave an interview to The Corner.


Pharmamar confirms Positive Results For Aplidin To Combat Coronavirus

PharmaMar’s shares were trading slightly lower, down 0.20%, at midday today. However that is following a rebound of 33% on Friday, making it the best performing stock on the Spanish stock market. This was after the company announced positive results from studies on Aplidin to combat the coronavirus. As a result, it will ask for tests to be carried out on infected patients.